FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108459650> ?p ?o ?g. }

• W2108459650 endingPage "393" @default.
• W2108459650 startingPage "384" @default.
• W2108459650 abstract "Bladder cancer is regarded as a promising candidate for innovative therapies in the field of immune and gene therapy. In this paper, we present the subcutaneous, metastatic and a novel orthotopic model of murine MB49 bladder cancer in C57BL/6 mice. We further show the potential of using adenoviral vectors together with different transduction enhancers to augment in vivo gene delivery. Finally, we present candidate genes for tumour detection, therapy or targeting. The MB49 tumour grew rapidly in mice. The subcutaneous model allowed for tumour detection within a week and the possibility to monitor growth rate on a day-by-day basis. Injection of MB49 cells intravenously into the tail vein gave rise to lung metastases within 16 days, while instillation of tumour cells into pretreated bladders led to a survival time of 20–40 days. Adenoviral vectors can be used as a vehicle for gene transfer to the bladder. By far, the most potent transduction enhancer was Clorpactin, also known as oxychlorosene. Last, we show that MB49 cells express tumour-associated antigens like bladder cancer-4, prostate stem cell antigen and six-transmembrane epithelial antigen of the prostate. Given the possibility for efficient genetic modification of the bladder and the presence of known tumour antigens, the MB49 models can be used in innovative ways to explore immunogene therapy." @default.
• W2108459650 created "2016-06-24" @default.
• W2108459650 creator A5039402380 @default.
• W2108459650 creator A5042590148 @default.
• W2108459650 creator A5054454657 @default.
• W2108459650 creator A5063027590 @default.
• W2108459650 creator A5072234235 @default.
• W2108459650 creator A5074196085 @default.
• W2108459650 date "2005-10-01" @default.
• W2108459650 modified "2023-09-27" @default.
• W2108459650 title "Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy" @default.
• W2108459650 cites W1891586069 @default.
• W2108459650 cites W1892170525 @default.
• W2108459650 cites W1969999666 @default.
• W2108459650 cites W1979288641 @default.
• W2108459650 cites W1993638034 @default.
• W2108459650 cites W1993956220 @default.
• W2108459650 cites W1996535081 @default.
• W2108459650 cites W2000073114 @default.
• W2108459650 cites W2001904774 @default.
• W2108459650 cites W2016160180 @default.
• W2108459650 cites W2016840392 @default.
• W2108459650 cites W2017476165 @default.
• W2108459650 cites W2047115293 @default.
• W2108459650 cites W2071737533 @default.
• W2108459650 cites W2078968390 @default.
• W2108459650 cites W2090375463 @default.
• W2108459650 cites W2101706701 @default.
• W2108459650 cites W2116291089 @default.
• W2108459650 cites W2125048328 @default.
• W2108459650 cites W2125266342 @default.
• W2108459650 cites W2128463911 @default.
• W2108459650 cites W2137745956 @default.
• W2108459650 cites W2146438145 @default.
• W2108459650 cites W2147203697 @default.
• W2108459650 cites W2151060435 @default.
• W2108459650 cites W2164907614 @default.
• W2108459650 cites W2313802299 @default.
• W2108459650 cites W2412492782 @default.
• W2108459650 doi "https://doi.org/10.1258/002367705774286475" @default.
• W2108459650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16197705" @default.
• W2108459650 hasPublicationYear "2005" @default.
• W2108459650 type Work @default.
• W2108459650 sameAs 2108459650 @default.
• W2108459650 citedByCount "38" @default.
• W2108459650 countsByYear W21084596502012 @default.
• W2108459650 countsByYear W21084596502013 @default.
• W2108459650 countsByYear W21084596502014 @default.
• W2108459650 countsByYear W21084596502015 @default.
• W2108459650 countsByYear W21084596502017 @default.
• W2108459650 countsByYear W21084596502018 @default.
• W2108459650 countsByYear W21084596502019 @default.
• W2108459650 countsByYear W21084596502021 @default.
• W2108459650 countsByYear W21084596502022 @default.
• W2108459650 crossrefType "journal-article" @default.
• W2108459650 hasAuthorship W2108459650A5039402380 @default.
• W2108459650 hasAuthorship W2108459650A5042590148 @default.
• W2108459650 hasAuthorship W2108459650A5054454657 @default.
• W2108459650 hasAuthorship W2108459650A5063027590 @default.
• W2108459650 hasAuthorship W2108459650A5072234235 @default.
• W2108459650 hasAuthorship W2108459650A5074196085 @default.
• W2108459650 hasConcept C104317684 @default.
• W2108459650 hasConcept C111599444 @default.
• W2108459650 hasConcept C121608353 @default.
• W2108459650 hasConcept C126322002 @default.
• W2108459650 hasConcept C135983454 @default.
• W2108459650 hasConcept C147483822 @default.
• W2108459650 hasConcept C15152581 @default.
• W2108459650 hasConcept C185592680 @default.
• W2108459650 hasConcept C203014093 @default.
• W2108459650 hasConcept C2777701055 @default.
• W2108459650 hasConcept C2780192828 @default.
• W2108459650 hasConcept C2780352672 @default.
• W2108459650 hasConcept C32470452 @default.
• W2108459650 hasConcept C40767141 @default.
• W2108459650 hasConcept C502942594 @default.
• W2108459650 hasConcept C55493867 @default.
• W2108459650 hasConcept C71924100 @default.
• W2108459650 hasConcept C8891405 @default.
• W2108459650 hasConceptScore W2108459650C104317684 @default.
• W2108459650 hasConceptScore W2108459650C111599444 @default.
• W2108459650 hasConceptScore W2108459650C121608353 @default.
• W2108459650 hasConceptScore W2108459650C126322002 @default.
• W2108459650 hasConceptScore W2108459650C135983454 @default.
• W2108459650 hasConceptScore W2108459650C147483822 @default.
• W2108459650 hasConceptScore W2108459650C15152581 @default.
• W2108459650 hasConceptScore W2108459650C185592680 @default.
• W2108459650 hasConceptScore W2108459650C203014093 @default.
• W2108459650 hasConceptScore W2108459650C2777701055 @default.
• W2108459650 hasConceptScore W2108459650C2780192828 @default.
• W2108459650 hasConceptScore W2108459650C2780352672 @default.
• W2108459650 hasConceptScore W2108459650C32470452 @default.
• W2108459650 hasConceptScore W2108459650C40767141 @default.
• W2108459650 hasConceptScore W2108459650C502942594 @default.
• W2108459650 hasConceptScore W2108459650C55493867 @default.
• W2108459650 hasConceptScore W2108459650C71924100 @default.
• W2108459650 hasConceptScore W2108459650C8891405 @default.
• W2108459650 hasIssue "4" @default.

• next